Latest News & Updates
Breaking News
17 hours ago
Simantini Singh Deo
Other trending news you may like to read
Idorsia Secures CHF 250 Million Loan from Pharmakon Advisors, Extending Cash Runway to 2028
Idorsia secures up to CHF 250M from Pharmakon Advisors, retiring a May 2027 debt maturity and extending cash runway into 2028.
Simantini Singh Deo
AstraZeneca Achieves 43% UPCR Reduction with Ultomiris in Phase III IgA Nephropathy Trial
Ultomiris hits 43.4% UPCR reduction at 34 weeks in Phase III IgA nephropathy trial, signalling a potential new indication filing with FDA and EMA.
Simantini Singh Deo
Eli Lilly Achieves Significant Fat Loss Outcomes in Oral GLP-1 Phase 3 Menopause Subgroup Analysis
Eli Lilly's oral GLP-1 candidate shows fat loss across menopause stages in Phase 3 ATTAIN trials, raising scale-up and formulation questions.
Simantini Singh Deo
Lupin Signs Deal with Laboratorios ERN to Launch Luforbec Inhaler Across Spain
Lupin partners with Laboratorios ERN to commercialise Luforbec in Spain, combining inhaler manufacturing depth with local distribution reach.
Simantini Singh Deo
